Merve Nur Ozdemir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Merve Nur Ozdemir has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Evren Algin Yapar
Department of Pharmaceutical Technology, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Türkiye
2 shared publications - Murat Kartal
Bezmialem Vakif University, Center of Education, Practice and Research in Phytotherapy, Bezmialem Vakif University,34093, Fatih, İstanbul, Turkey
2 shared publications - Ozlem Akbal-Dagistan
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye
2 shared publications - Simona Cavalu
University of Oradea, Oradea, Romania
2 shared publications - Yıldız Özsoy
Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye
2 shared publications Ahmet Arif Kurt
SÜLEYMAN DEMİREL ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ, ECZACILIK TEKNOLOJİSİ BÖLÜMÜ
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by Quality in Medicine, Education & Library in Journal of Immunology and Clinical Microbiology
- Vol. 10 (4) , 94-107
Antimicrobial activity studies of encapsulated hemp seed oil
Objective: In this study, it was aimed to evaluate to what extent the oil obtained from the seeds of the C. sativa plant affects the antimicrobial activity of liposome and liposome-gel formulations that will increase the stabilization, absorption and dispersion effect. Materials and Method: Hemp Seed Oil was used as an antimicrobial agent in our study. C. albicans was investigated as a microorganism. Eight different formulations were prepared from cannabis seed oil and the effect was examined by the spread plate method. Results: The most effective results were observed in the liposomal formulation containing Carbopol® Ultrez 30 compared to the formulation applications and control groups of Cannabis Seed Oil. In a smear sowing study with C. albicans, it was determined that the growth of Cannabis Seed Oil formulations and control groups was limited during one-week examinations. Conlusion: It was determined that the prepared Cannabis Seed Oil formulations had a highly inhibitory effect on the proliferation of C. albicans used in the study. Considering these results, it will lay the groundwork for studies that benefit from Cannabis Seed Oil and C. albicans.
- 31 December 2025
- Published by Quality in Medicine, Education & Library in Journal of Immunology and Clinical Microbiology
- Vol. 10 (4) , 94-107
Open AccessAntimicrobial activity studies of encapsulated hemp seed oil
Objective: In this study, it was aimed to evaluate to what extent the oil obtained from the seeds of the C. sativa plant affects the antimicrobial activity of liposome and liposome-gel formulations that will increase the stabilization, absorption and dispersion effect. Materials and Method: Hemp Seed Oil was used as an antimicrobial agent in our study. C. albicans was investigated as a microorganism. Eight different formulations were prepared from cannabis seed oil and the effect was examined by the spread plate method. Results: The most effective results were observed in the liposomal formulation containing Carbopol® Ultrez 30 compared to the formulation applications and control groups of Cannabis Seed Oil. In a smear sowing study with C. albicans, it was determined that the growth of Cannabis Seed Oil formulations and control groups was limited during one-week examinations. Conlusion: It was determined that the prepared Cannabis Seed Oil formulations had a highly inhibitory effect on the proliferation of C. albicans used in the study. Considering these results, it will lay the groundwork for studies that benefit from Cannabis Seed Oil and C. albicans.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (5) , 631-653
Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives
In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects. Their delivery with nanocarriers is on the agenda for phytochemicals to gain the targeted stability, effectiveness, and toxicity/safety properties. This review presents types of skin cancers, phytochemicals effective in skin cancers, and their nanocarrier-loaded studies from an up-to-date perspective.
- 1 April 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (5) , 631-653
Nanodelivery Approaches of Phytoactives for Skin Cancers: Current and Future Perspectives
In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects. Their delivery with nanocarriers is on the agenda for phytochemicals to gain the targeted stability, effectiveness, and toxicity/safety properties. This review presents types of skin cancers, phytochemicals effective in skin cancers, and their nanocarrier-loaded studies from an up-to-date perspective.
- 1 March 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (6) , 795-812
Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives
One of the most common malignancies in women, breast cancer accounts for nearly 25% of all cancer cases. Breast cancer is a diverse cancer form that exhibits variability in both morphology and molecular characteristics and is linked to numerous risk factors. Although various approaches and research are ongoing in the treatment and prevention of breast cancer, medication resistance in the current breast cancer treatment contributes to the disease's relapse and recurrence. Phytoactive molecules are the subject of growing research in both breast cancer prevention and treatment, but currently used conventional medicines and techniques limit their application. In recent years, significant advancements have been made in the field of nanotechnology, which has proven to be essential in the fight against drug resistance. The transport of synthetic and natural anticancer molecules via nanocarriers has recently been added to breast cancer therapy, greatly alleviating the constraints of the current approach. In light of these developments, interest in nano-delivery studies of phytoactive molecules has also increased. In this review, research of phytoactive molecules for breast cancers along with their clinical studies and nanoformulations, was presented from current and future perspectives.
- 1 March 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (6) , 795-812
Phytoactive Molecules and Nanodelivery Approaches for Breast Cancer Treatment: Current and Future Perspectives
One of the most common malignancies in women, breast cancer accounts for nearly 25% of all cancer cases. Breast cancer is a diverse cancer form that exhibits variability in both morphology and molecular characteristics and is linked to numerous risk factors. Although various approaches and research are ongoing in the treatment and prevention of breast cancer, medication resistance in the current breast cancer treatment contributes to the disease's relapse and recurrence. Phytoactive molecules are the subject of growing research in both breast cancer prevention and treatment, but currently used conventional medicines and techniques limit their application. In recent years, significant advancements have been made in the field of nanotechnology, which has proven to be essential in the fight against drug resistance. The transport of synthetic and natural anticancer molecules via nanocarriers has recently been added to breast cancer therapy, greatly alleviating the constraints of the current approach. In light of these developments, interest in nano-delivery studies of phytoactive molecules has also increased. In this review, research of phytoactive molecules for breast cancers along with their clinical studies and nanoformulations, was presented from current and future perspectives.